Seven Bridges

Seven Bridges Genomics (now operating as Velsera) is the leading biomedical data analysis company, specializing in software and data analytics to accelerate breakthroughs in genomics research across cancer, drug development, and precision medicine. The company delivers end-to-end bioinformatic solutions — encompassing access to large public and private datasets, analytic workflows and algorithms, cloud-computing infrastructure, and scientific support — that speed the path from raw experimental data to new treatments and diagnostics.

Seven Bridges serves both public and private sector partners, including biopharma organizations, national genomics programs, governments, academic institutions, and NGS-based healthcare companies. Its platform provides immediate access to more public datasets and bioinformatics tools than any comparable environment, enabling researchers to discover more from their genomic and clinical data.

Core Platform Capabilities

• Collaboration: Connect teams and data to fuel collaborative research and development within a secure, cloud-based environment, enabling seamless sharing across institutions and organizations.
• Discovery: Organize, explore, and empower omics data with new bioinformatic workflows and algorithms; streamline clinical trial research and increase speed to market for new diagnostics and therapeutics.
• Data & Compute: Immediate access to flexible and reproducible computation, centralized data storage, and a broad range of diverse public datasets to support large-scale genomic research.
• Security & Compliance: Comprehensive, integrated security features that meet or surpass regulatory requirements, keeping genomic information safe throughout the research lifecycle.

Key Products

• ARIA: A product within the Seven Bridges ecosystem supporting bioinformatics and data analysis workflows.
• GRAF™ (Graph-Based Reference): A pioneering graph-based genomics offering that supports research on underrepresented populations, large human population studies, and personalized genome graphs, advancing important human genome research.
• RHEO: An additional platform product supporting the broader bioinformatics ecosystem.
• Platform: The core cloud-based bioinformatics platform providing end-to-end data management, workflow execution, and collaborative research capabilities.

Solutions for Biopharma and NGS Healthcare

• Learn from the largest public genomic datasets alongside proprietary organizational data.
• Optimize workflows and accelerate biomarker discovery.
• Solve complex computational biology challenges at scale.
• Bring NGS-based healthcare applications to market faster with streamlined development pipelines.

Customized National Genomics Programs

• Deliver purpose-built data ecosystems designed to drive national-scale research and discovery.
• Operationalize end-to-end genomic data collection, curation, and analysis for population-level studies.
• Deploy new analytic methods for population-scale genomic research initiatives.
• Drive collaboration across institutions via secure and accessible data sharing frameworks.

Notable Partnerships and Customers

• Pancreatic Cancer Action Network: Partnership to develop a high-quality, actionable cancer data platform, evolving the data sharing paradigm to rapidly bring clinical trial data to the research community.
• CareDx: Selected to advance transplant care solutions, with the Seven Bridges Bioinformatics Ecosystem supporting critical turnaround times for the CareDx AlloSure® 3.0 workflow.
• Additional case study partners include e-NIOS, Becton Dickinson, Bristol-Myers Squibb, NCI-CGR, and PCAWG, reflecting a broad customer base spanning pharma, diagnostics, and government research programs.

Seven Bridges, now part of Velsera, continues to expand its integrated offerings, combining all existing products and services with new solutions aimed at further connecting biomedical data, teams, and analytical capabilities to accelerate discoveries in genomics and precision medicine.